Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Debt Ratio (2020 - 2026)

Updated

Raphael Pharmaceutical's Debt Ratio came in at 187.14 for Q2 2026, up 895.4% from 18.80 a year earlier.

Analysis

Raphael Pharmaceutical (RAPH) Debt Ratio (2020 - 2026) Analysis & Trends

For FY2025, Raphael Pharmaceutical's Debt Ratio was 17.85, up 111.4% from FY2024.

  • Going back by year, Debt Ratio was 8.44 in FY2024, 0.32 in FY2023 and 0.02 in FY2022.
  • The Q2 2026 figure represents the highest quarterly Debt Ratio in data going back to Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn - 187.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187.14
Dec 31, 2025 17.85
Sep 30, 2025 107.86
Jun 30, 2025 18.80
Mar 31, 2025 4.38
Dec 31, 2024 8.44
Sep 30, 2024 2.55
Jun 30, 2024 0.20
Mar 31, 2024 0.10
Dec 31, 2023 0.32
Sep 30, 2023 0.10
Jun 30, 2023 0.33
Dec 31, 2022 0.02
Dec 31, 2020 1.11
API Access

Raphael Pharmaceutical Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RAPH&period=max&api_key=YOUR_API_KEY